Related Experiment Video
Updated: Aug 19, 2025
Method of Studying Palatal Fusion using Static Organ Culture
Published on: September 19, 2015
From Bedside to Bench and Back: Advancing Our Understanding of the Pathophysiology of Cleft Palate and Implications
Eloise Stanton1,2, Samuel Sheridan3, Mark Urata3,4
1Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA, USA.
Insights
Understanding cleft palate (CP) pathophysiology is advancing through animal models, but clinical translation requires bridging knowledge gaps. Future treatments may involve precision medicine and enhanced collaboration between researchers and clinicians.
Area of Science:
- Developmental Biology
- Craniofacial Research
- Regenerative Medicine
Background:
- Cleft palate (CP) presents complex challenges in understanding its underlying molecular and cellular mechanisms.
- Animal models, particularly mice, have been instrumental in elucidating CP pathophysiology and guiding therapeutic development.
Purpose of the Study:
- To comprehensively review the pathophysiology of cleft palate (CP).
- To explore future perspectives and potential treatment modalities for CP management.
- To identify barriers and opportunities in translating animal research findings to human clinical applications.
Main Methods:
- A thorough literature review was conducted.
- Studies encompassed diverse healthcare settings and geographical locations.
- No experimental interventions were performed; the focus was on synthesizing existing knowledge.
Main Results:
- Animal research offers significant insights into CP's molecular and cellular underpinnings, paving the way for novel treatment strategies.
- Translating findings from mouse models to human CP requires further investigation due to species-specific differences in palatogenesis and tissue repair.
- Tissue regeneration successes in mice suggest promising avenues for precision medicine in cleft care, though clinical translation barriers persist.
Conclusions:
- Bridging the knowledge gap between animal models and human CP necessitates increased translation of pathophysiological and tissue regeneration studies into clinical trials.
- Enhanced collaboration between basic scientists and clinicians is crucial for developing targeted treatment algorithms.
- Integrating animal model findings with clinical observations will refine patient management strategies for CP.
Objective:
To provide a comprehensive understanding of the pathophysiology of cleft palate (CP) and future perspectives.
Design:
Literature review.
Setting:
Setting varied across studies by level of care and geographical locations.
Interventions:
No interventions were performed.
Main Outcome Measure(S):
Primary outcome measures were to summarize our current understanding of palatogenesis in humans and animal models, the pathophysiology of CP, and potential future treatment modalities.
Results:
Animal research has provided considerable insight into the pathophysiology, molecular and cellular mechanisms of CP that have allowed for the development of novel treatment strategies. However, much work has yet to be done to connect our mouse model investigations and discoveries to CP in humans. The success of innovative strategies for tissue regeneration in mice provides promise for an exciting new avenue for improved and more targeted management of cleft care with precision medicine in patients. However, significant barriers to clinical translation remain. Among the most notable challenges include the differences in some aspects of palatogenesis and tissue repair between mice and humans, suggesting that potential therapies that have worked in animal models may not provide similar benefits to humans.
Conclusions:
Increased translation of pathophysiological and tissue regeneration studies to clinical trials will bridge a wide gap in knowledge between animal models and human disease. By enhancing interaction between basic scientists and clinicians, and employing our animal model findings of disease mechanisms in concert with what we glean in the clinic, we can generate a more targeted and improved treatment algorithm for patients with CP.
More Related Videos
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
01:24Cystic Fibrosis: Management
Sinus disease and chronic...
01:20Taste Buds and Receptors